San Jose, CA, United States of America

Lily Gong

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Lily Gong

Introduction

Lily Gong is a prominent inventor based in San Jose, CA, known for her significant contributions to the field of medicine. With a focus on treating epilepsy, she has developed innovative methods that have the potential to improve the lives of many patients. Her work is characterized by a commitment to advancing medical treatments through her inventive spirit.

Latest Patents

Lily Gong holds 3 patents that showcase her expertise and dedication to medical innovation. Her latest patents include a method of treating epilepsy using Alprazolam formulated as an inhaled condensation aerosol. This innovative approach aims to provide effective treatment for epilepsy and/or seizures, highlighting her focus on improving patient outcomes.

Career Highlights

Lily Gong is currently employed at Alexza Pharmaceuticals, Inc., where she continues to push the boundaries of medical research and development. Her role at the company allows her to collaborate with other talented professionals in the field, further enhancing her contributions to medical science.

Collaborations

Throughout her career, Lily has worked alongside notable colleagues such as James Cassella and Edwin S Kamemoto. These collaborations have played a crucial role in her innovative projects and have contributed to the success of her patents.

Conclusion

Lily Gong's work exemplifies the impact of innovation in the medical field, particularly in the treatment of epilepsy. Her patents and collaborations reflect her dedication to improving healthcare through inventive solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…